Abstracts tagged "Femur Fractures"

Abstract Number: 2233 • 2019 ACR/ARP Annual Meeting
Hip Fracture Incidence in a Teaching Hospital: Intervention for the Prevention of Second Hip Fracture
Xavier González-Giménez¹, Carmen Gomez-Vaquero ², Lidia Valencia-Muntala ³, Andrea Zacarias ¹, Irene Martin ⁴, Carles Tramunt ⁵ and Ana-Belen Redondo ⁶, ¹Hospital Universitari de Bellvitge. Rheumatology Department, Barcelona, Spain, ²Hospital Universitari de Bellvitge. Rheumatology Department, El Prat, Spain, ³Hospital Universitari de Bellvitge. Rheumatology Department, Cervello, Spain, ⁴Hospital General Mateu Orfila. Rheumatology Department, Mao, Spain, ⁵Hospital Universitari de Bellvitge. Orthopaedics Surgery Department, Barcelona, Spain, ⁶Hospital Universitari de Bellvitge. Technical Secretary, Barcelona, Spain
Background/Purpose: Since March 2009, every patient who was admitted in the Orthopaedic Surgery Department for a hip fracture (HF) was evaluated during the admission period…
Abstract Number: 350 • 2015 ACR/ARHP Annual Meeting
Atypical Femur Fracture in Rheumatoid Arthritis Patients Treated with Bisphosphonates: A Nested Case-Control Study
JungHee Koh¹, Ji Hyeon Ju², Min Kyung Chung³, Ji Hun Kim³, Seung Min Jung⁴, Ji Yeon Lee², Jennifer Lee³, Seung-Ki Kwok⁵ and Sung-Hwan Park³, ¹Seochogu, Banpodaero, 222, Division of Rheumatology, Department of Internal Medicine, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea, ²Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, ³Division of Rheumatology, Department of Internal Medicine, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea, ⁴Division of Rheumatology, Department of Internal Medicine, school of medicine, The catholic university of Korea, Seoul, South Korea, ⁵[email protected], Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea
Background/Purpose: Patients with rheumatoid arthritis (RA) are diagnosed with osteoporosis earlier than and those without RA, and are therefore exposed to Bisphosphonates (BPs) for longer.…
Abstract Number: 1805 • 2014 ACR/ARHP Annual Meeting
Prevalence and Associating Factors with Atypical Femoral Fractures: An Asian Single Center Based Case-Control Study
Dam Kim¹, Yoon-Kyoung Sung^2,3, Soo-Kyung Cho^1,3, Minkyung Han¹ and Yee-Suk Kim⁴, ¹Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, ²Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ³Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ⁴Department of Orthopedic Surgery, Hanyang University Hospital, Seoul, South Korea
Background/Purpose Although the use of bisphosphonates has been shown to reduce vertebral and proximal femur fracture risk in patients with osteoporosis, current evidence suggests that…
Abstract Number: 51 • 2014 ACR/ARHP Annual Meeting
High Incidence of Non-Vertebral Osteoporotic Fracture and Hip Fracture in Brazilian Low-Income Community-Dwelling Elderly: A Population-Based Prospective Cohort Analysis from the São Paulo Ageing & Health (SPAH) Study
Diogo S. Domiciano¹, Luana G. Machado², Jaqueline B. Lopes², Camille P. Figueiredo², Valéria Caparbo², Liliam Takayama², Ricardo Oliveira³, Paulo R Menezes⁴ and Rosa M. R. Pereira⁵, ¹Rheumatology, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil, ²Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ³RDO Diagnósticos Médicos, São Paulo, Brazil, ⁴Preventive Medicine, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil, ⁵Reumatologia, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil
Background/Purpose: There is considerable variability in the incidence of hip fracture among countries, even among different geographical areas within the same country. In Brazil, population…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].